{"id":48955,"date":"2023-05-15T06:30:31","date_gmt":"2023-05-15T06:30:31","guid":{"rendered":"https:\/\/www.arisglobal.com\/?p=48955"},"modified":"2023-05-15T06:30:31","modified_gmt":"2023-05-15T06:30:31","slug":"biopharma-modernizes-pharmacovigilance-operations","status":"publish","type":"post","link":"https:\/\/www.arisglobal.com\/blogs\/biopharma-modernizes-pharmacovigilance-operations\/","title":{"rendered":"How Leading South Korean Biopharma LSK is Modernizing Pharmacovigilance Operations with ArisGlobal"},"content":{"rendered":"

South Korean Contract Research Organization, LSK, spoke in a webinar with ArisGlobal to address the pressures of modernizing pharmacovigilance operations<\/a> in the current landscape, including how South Korean biopharma firms are navigating evolving regulatory requirements, and how they are seizing the opportunity provided by advancements in end-to-end safety automation.<\/p>\n

<\/h2>\n

Challenges for many South Korean CROs<\/h2>\n

Traditional safety workflows are inefficient, labor-intensive, and contain multiple manual, time-consuming steps. They are also cost-effective to scale, which makes it difficult to stay cost-competitive and efficiently deliver the level of service that clients expect (or demand). To grow a serviceable market, CROs and service providers need to meet increasingly complex global regulations, but manually ensuring compliance across global clients increases costs and complexities are challenging.<\/p>\n

Legacy workflows impair the ability to process higher case volumes and add new services. This makes it harder to scale post-market operations and be a one-stop-shop vendor.<\/p>\n

<\/h2>\n

The State of Pharmacovigilance Regulation Updates in South Korea<\/h2>\n

Globally, pharmacovigilance regulations are constantly changing in terms of analyzing safety information worldwide. Increasing demand and industry competition, partnered with complex regulations and global operations makes for a complex landscape to navigate.
\nSince South Korea became a member of the International Council for Harmonisation<\/a> (ICH) in 2016, there have been many changes in regulatory requirements that CROs, like LSK, have had to navigate:<\/p>\n